Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Eva L. Kneepkens
Observed names:
E L Kneepkens,
E. Kneepkens,
E.L. Kneepkens,
EL Kneepkens,
Eva L Kneepkens,
Kneepkens, Eva
show all 6
Observed institutions:
Hospital Universitario La Paz,
Sanquin,
Reade,
OLVG,
University of Amsterdam,
Amsterdam UMC Location Vrije Universiteit Amsterdam
show all 6
OpenAlex ID:
A5113848726
Immunogenicity, adalimumab levels and clinical response in ankylosing spondylitis patients during 24 weeks of follow-up
2013
·
Eva L Kneepkens
, James Cheng-Chung Wei
, et al.
·
Annals of the Rheumatic Diseases
·
91
Medication-Related Hospital Readmissions Within 30 Days of Discharge: Prevalence, Preventability, Type of Medication Errors and Risk Factors
2021
·
Elien B. Uitvlugt
, Marjo J. A. Janssen
, et al.
·
Frontiers in Pharmacology
·
90
PDF
Anti-adalimumab antibodies and adalimumab concentrations in psoriatic arthritis; an association with disease activity at 28 and 52 weeks of follow-up
2014
·
Erik H Vogelzang
, Eva L Kneepkens
, et al.
·
Annals of the Rheumatic Diseases
·
88
Lower etanercept levels are associated with high disease activity in ankylosing spondylitis patients at 24 weeks of follow-up
2014
·
E L Kneepkens
, C L M Krieckaert
, et al.
·
Annals of the Rheumatic Diseases
·
59
Capillary Blood Microsampling to Determine Serum Biopharmaceutical Concentration: Mitra ® Microsampler vs Dried Blood Spot
2018
·
Karien Bloem
, Tiny Schaap
, et al.
·
Bioanalysis
·
55
Dried blood spots from finger prick facilitate therapeutic drug monitoring of adalimumab and anti‐adalimumab in patients with inflammatory diseases
2017
·
Eva L. Kneepkens
, Mieke F. Pouw
, et al.
·
British Journal of Clinical Pharmacology
·
46
Serum tocilizumab trough concentration can be used to monitor systemic IL-6 receptor blockade in patients with rheumatoid arthritis: a prospective observational cohort study
2016
·
EL Kneepkens
, IAM van den Oever
, et al.
·
Scandinavian Journal of Rheumatology
·
43
PDF
Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study
2016
·
Sophie J. Bernelot Moens
, Fleur M. van der Valk
, et al.
·
Arthritis Research & Therapy
·
38
Comparing Tapering Strategy to Standard Dosing Regimen of Tumor Necrosis Factor Inhibitors in Patients with Spondyloarthritis in Low Disease Activity
2015
·
Chamaida Plasencia
, Eva L. Kneepkens
, et al.
·
The Journal of Rheumatology
·
36
PDF
Adalimumab trough concentrations in patients with rheumatoid arthritis and psoriatic arthritis treated with concomitant disease-modifying antirheumatic drugs
2014
·
E H Vogelzang
, M F Pouw
, et al.
·
Annals of the Rheumatic Diseases
·
33
Golimumab trough levels, antidrug antibodies and clinical response in patients with rheumatoid arthritis treated in daily clinical practice
2014
·
Eva L Kneepkens
, Chamaida Plasencia
, et al.
·
Annals of the Rheumatic Diseases
·
33
Preventability of unplanned readmissions within 30 days of discharge. A cross-sectional, single-center study
2020
·
Albertine M. B. van der Does
, Eva L. Kneepkens
, et al.
·
PLoS ONE
·
32
PDF
Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a randomized controlled trial
2022
·
J Ruwaard
, MJ L’ Ami
, et al.
·
Scandinavian Journal of Rheumatology
·
27
PDF
The Effects of 5-year Etanercept Therapy on Cardiovascular Risk Factors in Patients with Psoriatic Arthritis
2017
·
Rabia Agca
, Maaike Heslinga
, et al.
·
The Journal of Rheumatology
·
20
PDF
Association between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis
2019
·
Borja Hernández-Breijo
, Chamaida Plasencia-Rodríguez
, et al.
·
Arthritis Research & Therapy
·
18
PDF
Comparison of drug survival and clinical outcome in patients with ankylosing spondylitis treated with etanercept or adalimumab
2017
·
J Ruwaard
, MJ l’Ami
, et al.
·
Scandinavian Journal of Rheumatology
·
15
PDF
Impact of Stopping Tumor Necrosis Factor Inhibitors on Rheumatoid Arthritis Patients’ Burden of Disease
2017
·
Marjan Ghiti Moghadam
, Peter M. ten Klooster
, et al.
·
Arthritis Care & Research
·
14
PDF
Search for a concentration–effect curve of adalimumab in ankylosing spondylitis patients
2016
·
AF Marsman
, EL Kneepkens
, et al.
·
Scandinavian Journal of Rheumatology
·
11
Continuous Improvement of Physical Functioning in Ankylosing Spondylitis Patients by Tumor Necrosis Factor Inhibitors: Three‐Year Followup and Predictors
2016
·
Salima F. E. van Weely
, Eva L. Kneepkens
, et al.
·
Arthritis Care & Research
·
9
PDF
Comparing a tapering strategy to the standard dosing regimen of TNF inhibitors in rheumatoid arthritis patients with low disease activity.
2016
·
Chamaida Plasencia
, Gertjan Wolbink
, et al.
·
PubMed
·
8
Long-term treatment response in rheumatoid arthritis patients starting adalimumab or etanercept with or without concomitant methotrexate.
2017
·
Merel J l'Ami
, Eva L Kneepkens
, et al.
·
PubMed
·
7
OP0074 A Concentration-Effect Curve of Adalimumab in Patients with Psoriatic Arthritis
2014
·
E. Vogelzang
, E. Kneepkens
, et al.
·
Annals of the Rheumatic Diseases
·
3
SAT0391 A Diminished Clinical Response at 28 and 52 Weeks of Adalimumab Treatment in Patients with Psoriatic Arthritis is Associated with Anti-Drug Antibodies
2014
·
E. Vogelzang
, E. Kneepkens
, et al.
·
Annals of the Rheumatic Diseases
·
3
FRI0426 Immunogenicity, adalimumab levels and clinical response in ankylosing spondylitis patients during 24 weeks of follow-up.
2013
·
E.L. Kneepkens
, J.C. Wei
, et al.
·
Annals of the Rheumatic Diseases
·
3
FRI0186 Concomitant csdmards influence clinical response to tnf inhibitors only in overweight patients with axial spondyloarthritis
2018
·
B. Hernández-Breijo
, V. Navarro-Compán
, et al.
·
Annals of the Rheumatic Diseases
·
2
PDF
Show more works
View as search
Works count:
48
Citation count:
794
H-index:
15
I10-index:
18
Year
Topic
Type
